Genomic Valley Biotech Limited

BSE:539206 Stock Report

Market Cap: ₹271.7m

Genomic Valley Biotech Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Yogesh Agrawal

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.6yrs
CEO ownership47.2%
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Yogesh Agrawal's remuneration changed compared to Genomic Valley Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹2m

Jun 30 2024n/an/a

₹1m

Mar 31 2024n/an/a

₹152k

Dec 31 2023n/an/a

₹11m

Sep 30 2023n/an/a

₹2m

Jun 30 2023n/an/a

₹2m

Mar 31 2023₹600k₹600k

₹6m

Dec 31 2022n/an/a

-₹2m

Sep 30 2022n/an/a

₹7m

Jun 30 2022n/an/a

₹6m

Mar 31 2022₹550k₹550k

-₹93k

Dec 31 2021n/an/a

-₹5m

Sep 30 2021n/an/a

-₹6m

Jun 30 2021n/an/a

-₹5m

Mar 31 2021n/an/a

-₹6m

Dec 31 2020n/an/a

-₹155k

Sep 30 2020n/an/a

₹909k

Jun 30 2020n/an/a

₹1m

Mar 31 2020₹450k₹450k

₹3m

Dec 31 2019n/an/a

₹3m

Sep 30 2019n/an/a

₹2m

Jun 30 2019n/an/a

₹2m

Mar 31 2019₹900k₹900k

₹2m

Dec 31 2018n/an/a

₹1m

Sep 30 2018n/an/a

₹448k

Jun 30 2018n/an/a

₹380k

Mar 31 2018₹2m₹2m

₹341k

Compensation vs Market: Insufficient data to establish whether Yogesh's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Yogesh's compensation has been consistent with company performance over the past year.


CEO

Yogesh Agrawal (60 yo)

1.6yrs

Tenure

Mr. Yogesh Agrawal serves as Managing Director and Chairman at Genomic Valley Biotech Ltd and has been its Director since March 15, 1996 and served as its Compliance Officer and Company Secretary since May...


Board Members

NamePositionTenureCompensationOwnership
Yogesh Agrawal
MD, Chairman & CFO28.8yrsno data47.17%
₹ 128.2m
Parul Agrawal
Additional Non-Independent & Non-Executive Directorless than a yearno data0%
₹ 0
Satendra Goyal
Independent Directorless than a yearno datano data
Ashok Kumar Khattar
Additional Non- Executive Independent Director1.2yrsno datano data
Ashok Kumar
Non-Executive Non-Independent Directorless than a yearno datano data

0.9yrs

Average Tenure

61yo

Average Age

Experienced Board: 539206's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 18:52
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genomic Valley Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution